Cargando…
Comparative DNA methylome analysis of endometrial carcinoma reveals complex and distinct deregulation of cancer promoters and enhancers
BACKGROUND: Aberrant DNA methylation is a hallmark of many cancers. Classically there are two types of endometrial cancer, endometrioid adenocarcinoma (EAC), or Type I, and uterine papillary serous carcinoma (UPSC), or Type II. However, the whole genome DNA methylation changes in these two classical...
Autores principales: | Zhang, Bo, Xing, XiaoYun, Li, Jing, Lowdon, Rebecca F, Zhou, Yan, Lin, Nan, Zhang, Baoxue, Sundaram, Vasavi, Chiappinelli, Katherine B, Hagemann, Ian S, Mutch, David G, Goodfellow, Paul J, Wang, Ting |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4198682/ https://www.ncbi.nlm.nih.gov/pubmed/25286960 http://dx.doi.org/10.1186/1471-2164-15-868 |
Ejemplares similares
-
Whole-Genome DNA Methylation Profiling Identifies Epigenetic Signatures of Uterine Carcinosarcoma()()
por: Li, Jing, et al.
Publicado: (2017) -
Developmental enhancers revealed by extensive DNA methylome maps of zebrafish early embryos
por: Lee, Hyung Joo, et al.
Publicado: (2015) -
Methylomic profiling and replication implicates deregulation of PCSK9 in alcohol use disorder
por: Lohoff, Falk W., et al.
Publicado: (2017) -
Glycogen Synthase Kinase 3β Inhibition as a Therapeutic Approach in the Treatment of Endometrial Cancer
por: Yin, Yan, et al.
Publicado: (2013) -
The influence of menstrual cycle and endometriosis on endometrial methylome
por: Saare, Merli, et al.
Publicado: (2016)